Biology of Osteosarcoma (BOOST) Registry and Biobank
NCT03225872 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 362
Last updated 2025-12-02
Summary
Osteosarcoma is very rare cancer of the bone. The investigator started the BOOST registry and biobank to make sure every patient has the opportunity to participate in research.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Logan G. Spector, PhD · University of Minnesota
Eligibility
- Min Age
- 0 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-01-03
- Primary Completion
- 2020-01-27
- Completion
- 2020-01-27
Countries
- United States
Study Locations
More Related Trials
-
Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma
NCT01807143 ·Status: COMPLETED
-
Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma
NCT01374672 ·Status: COMPLETED
-
Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction
NCT00588510 ·Status: COMPLETED
-
Proteomics Research of Osteosarcoma
NCT03932058 ·Status: UNKNOWN
-
Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC
NCT02436772 ·Status: COMPLETED
-
The Prognostic Value of Serum Biomarkers in Osteosarcoma
NCT05093101 ·Status: COMPLETED
-
Cytogenetic and Molecular Genetic Studies in Bone Sarcomas
NCT00579930 ·Status: COMPLETED
-
Biology Studies of Hematologic Cancers
NCT00923442 ·Status: ENROLLING_BY_INVITATION
-
Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma
NCT00588198 ·Status: COMPLETED
-
New Biopsy Technique for Uveal Melanoma
NCT01924923 ·Status: COMPLETED
-
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
NCT00899275 ·Status: COMPLETED
-
DNA Biomarkers in Tissue Samples From Patients With Osteosarcoma
NCT01190943 ·Status: COMPLETED
-
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
NCT00899496 ·Status: COMPLETED
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED
-
Identification and Characterization of Predictive Factors of Onset of Bone Metastases in Cancer Patients
NCT03895216 ·Status: COMPLETED
-
Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia
NCT00899613 ·Status: UNKNOWN
-
Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer
NCT01325142 ·Status: COMPLETED
-
An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
NCT02677961 ·Status: RECRUITING
-
Consent for Obtaining Additional Bone Marrow Specimens at Time of Diagnostic Bone Marrow Procedure
NCT01048060 ·Status: TERMINATED
-
Pathogenesis of Hematologic Malignancies
NCT01728402 ·Status: ENROLLING_BY_INVITATION
-
Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)
NCT06377527 ·Status: RECRUITING
-
Whole-Exome Sequencing (WES) of Cancer Patients
NCT02127359 ·Status: COMPLETED
-
The American Society of Hematology (ASH) Research Registry: A Multicenter Research Registry of Patients With Hematologic Disease
NCT03535220 ·Status: UNKNOWN
-
The Registry of Oncology Outcomes Associated with Testing and Treatment
NCT04028479 ·Status: COMPLETED
-
The Leukemia and Lymphoma Society (LLS) National Research Registry
NCT04806295 ·Status: RECRUITING